Home・Elenco Azioni・OPKO Health Inc

OPKO Health Inc

Chiusa

SettoreSettore sanitario

1.56 0.65

Acquista Vendi

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

1.54

Massimo

1.56

Metriche Chiave
By Trading Economics
Entrata	46M -8.4M
Vendite	39M 164M
EPS	-0.01
Margine di Profitto	-5.145
Dipendenti	2,275
EBITDA	40M 12M

Raccomandazioni
By TipRanks
Raccomandazioni	Acquista
Previsioni per 12 mesi	+92.31% upside

Dividendi
By Acuity
Utili prossimi	28 ott 2026

Statistiche di mercato
By TradingEconomics
Capitalizzazione di Mercato	258M 1.2B
Apertura precedente	0.91
Chiusura precedente	1.56

Notizie sul Sentiment di mercato

By Acuity

50%

129 / 339 Classifica in Healthcare

OPKO Health Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

15 set 2026, 23:11 UTC

OPKO Health Inc shares are higher in after-market trading, advancing from a low of 1.28% to a high of 1.92% since Tuesday's close.

14 set 2026, 20:08 UTC

News

OPKO Health has expanded its financing with HealthCare Royalty, securing $125 million in senior secured notes linked to future royalty payments in China.

11 set 2026, 20:01 UTC

OPKO Health Inc shares are higher, continuing gains since Thursday's close. The stock rebounded after an early dip, with no specific news driving the movement.

9 set 2026, 19:16 UTC

OPKO Health Inc. shares are lower today amid broader market pressures from rising oil prices above $100 per barrel and inflation concerns.

8 set 2026, 23:36 UTC

No specific news was identified for OPKO Health Inc. Shares traded roughly flat after market hours, remaining near the upper end of their one-month range.

4 set 2026, 20:07 UTC

OPKO Health Inc. shares are higher today, rebounding significantly after an initial dip and currently 12.75% above the 20-day moving average.

3 set 2026, 21:02 UTC

OPKO Health Inc. is higher in after-hours trading, reflecting gains since Thursday's close amid declining Treasury yields and improved investor sentiment.

2 set 2026, 23:46 UTC

OPKO Health Inc. shares were roughly flat during after-market hours, maintaining a significant one-month increase of about 29%.

1 set 2026, 20:01 UTC

OPKO Health shares are higher today, remaining above their 20-day moving average amid rising oil prices and inflation concerns affecting the broader market.

28 ago 2026, 19:16 UTC

OPKO Health Inc. shares are lower today, having reached a session low. The stock remains within its one-month trading range and above the 20-day moving average.

27 ago 2026, 23:01 UTC

OPKO Health Inc. shares are higher in after-market trading, reflecting strong performance since Thursday's close and maintaining a position above its 20-day moving average.

26 ago 2026, 20:08 UTC

OPKO Health Inc shares are higher during Wednesday's session, maintaining a position above the 20-day moving average amid mixed broader market performance.

25 ago 2026, 19:36 UTC

OPKO Health Inc. shares are higher today, remaining above their 20-day moving average despite earlier fluctuations during the session.

24 ago 2026, 22:01 UTC

OPKO Health Inc. shares are lower in after-market trading, reflecting a shift in momentum since Monday's close. The stock remains above its 20-day moving average.

21 ago 2026, 23:56 UTC

OPKO Health Inc. shares declined in after-market trading, despite gains in major stocks as the broader market rebounded from earlier pressures.

20 ago 2026, 19:56 UTC

OPKO Health Inc. shares are higher today, maintaining a position above their 20-day moving average amid no specific company news identified.

19 ago 2026, 20:02 UTC

OPKO Health Inc shares are higher in Wednesday's session, recovering from an early dip. The stock remains above its 20-day moving average.

18 ago 2026, 19:16 UTC

OPKO Health Inc shares are lower amid broader market declines, influenced by rising Treasury yields and inflation concerns following a significant drop in housing starts.

17 ago 2026, 19:06 UTC

News

OPKO Health Inc. shares are lower today, continuing a decline since Friday. The company issued $125 million in senior secured notes linked to mazdutide royalties.

14 ago 2026, 19:36 UTC

OPKO Health Inc shares are lower amid broader market concerns following a reported decline in retail sales for July. The stock reached a session low earlier.

13 ago 2026, 23:01 UTC

OPKO Health shares lower in after-market trading, declining since Thursday's close amid mixed macroeconomic signals and uncertainty in the market.

12 ago 2026, 19:36 UTC

OPKO Health Inc shares are modestly higher, reflecting a positive market environment amid recent risk asset gains. Core CPI data aligns with forecasts, supporting steady interest rates.

11 ago 2026, 19:36 UTC

OPKO Health Inc shares are higher, maintaining a position above their 20-day moving average amid broader market sentiment influenced by geopolitical tensions and inflation reports.

10 ago 2026, 19:46 UTC

OPKO Health Inc. shares are trading higher amid broader market uncertainty, reflecting notable strength above its 20-day moving average since Friday's close.

7 ago 2026, 23:01 UTC

OPKO Health shares advanced in after-market trading, recovering from earlier losses amid broader market dynamics and a slight decline in the unemployment rate.

6 ago 2026, 19:16 UTC

OPKO Health Inc. shares are lower today amid notable volatility, with economic data showing initial jobless claims rose slightly ahead of tomorrow's non-farm payrolls report.

5 ago 2026, 23:01 UTC

OPKO Health shares are lower in after-market hours, reflecting broader market weakness amid recent economic data showing weaker-than-expected U.S. job growth.

4 ago 2026, 23:06 UTC

OPKO Health Inc. shares are higher in after-market trading, settling with a cumulative gain following a brief dip at the session's start.

3 ago 2026, 23:01 UTC

OPKO Health Inc shares increased in after-market trading, maintaining a steady rise since Monday's close amid a generally positive market backdrop.

31 lug 2026, 19:45 UTC

OPKO Health Inc. shares are trading roughly flat today, hovering around the middle of their one-month range and above the 20-day moving average.

Confronto tra pari

Modifica del prezzo

OPKO Health Inc Previsione

Obiettivo di Prezzo

By TipRanks

92.31% in crescita

Previsioni per 12 mesi

Media 3 USD 92.31%

Alto 3 USD

Basso 3 USD

Basato su 3 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per OPKO Health Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

3 ratings

Acquista

Mantieni

Vendi

Basato sugli analisti di 3 che hanno fornito valutazioni azionarie a OPKO Health Inc - Dist negli ultimi 3 mesi.

Sentiment

By Acuity

129 / 339 Classifica in Settore sanitario

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

Chi Siamo OPKO Health Inc

OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Spain, Chile, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases, including esoteric testing, molecular diagnostics, anatomical pathology, genetics, women's health, and correctional healthcare to physician offices, clinics, hospitals, employers, and governmental units; and 4Kscore prostate cancer test. Its Pharmaceutical segment offers Rayaldee to treat secondary hyperparathyroidism in adults with stage 3 or 4 chronic kidney disease, and vitamin D insufficiency. This segment also develops multi-specific immune therapies focused on oncology, infectious diseases, vaccines, and immunology; OPK88004, an orally administered selective androgen receptor modulator; OPK88003, a once-weekly administered peptide for the treatment of type 2 diabetes and related obesity; Somatrogon (hGH-CTP), a once-weekly human growth hormone injection; and Factor VIIa-CTP, a novel long-acting coagulation factor being developed to treat hemophilia. In addition, it develops and commercializes longer-acting proprietary versions of already approved therapeutic proteins; develops and produces specialty APIs; develops, manufactures, markets, and sells pharmaceutical, nutraceutical, veterinary, and ophthalmic products; commercializes food supplements and over the counter products; manufactures and sells products primarily in the generics market; and markets, distributes, and sells pharmaceutical products in a range of indications, including cardiovascular products, vaccines, antibiotics, gastro-intestinal products, hormones, and others. The company also operates pharmaceutical platforms in Ireland, Chile, Spain, and Mexico. The company was founded in 2007 and is headquartered in Miami, Florida.